通过对瘤反应的纳米材料增强免疫疗法
Stephen W Linderman1,2, Louis DeRidder3,4, Lucía Sanjurjo5,6
1Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nature reviews. Clinical oncology
|March 6, 2025
概括
响应瘤的纳米材料提供向的癌症免疫疗法,克服了全身管理问题. 这些智能材料利用瘤微环境 (TME) 来提高治疗效率和改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 系统性免疫疗法面临着诸如非瘤毒性和由于免疫抑制瘤微环境 (TME) 的有限疗效等挑战.
- 需要有针对性的输送系统来克服这些局限性并提高治疗结果.
研究的目的:
- 审查针对癌症免疫治疗的瘤响应纳米材料的开发和应用.
- 探索如何利用TME特征来提高纳米医学基础免疫疗法的特异性和有效性.
主要方法:
- 对基于纳米材料的免疫疗法进行的临床前研究和临床试验的审查.
- 对TME特异性触发因素 (pH,酶,缺氧等) 的分析. 对于纳米材料货物的释放.
- 通过纳米材料输送的各种免疫治疗剂的评估 (例如检查点抑制剂,细胞因子,mRNA疫苗).
主要成果:
- 设计以响应TME线索的纳米材料在向药物输送方面显示出前景.
- 成功的临床前研究表明,疗效提高,毒性降低.
- 几种方法正在进入临床试验,表明治疗潜力.
结论:
- 响应瘤的纳米材料代表了癌症免疫疗法的重大进步.
- 利用TME动态提供了一种提高特异性和克服治疗耐药性的战略.
- 进一步的研究和临床转化至关重要,以实现这些创新疗法的全部潜力,以改善患者的治疗结果.
更多相关视频
05:06Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
886
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
